CLOSE
BACK

OUR FUNDS

CLOSE

Harding Loevner International Fund

An International Fund targeting superior risk-adjusted returns through investing in high-quality and durable growing companies at reasonable prices.

October 2023 - Monthly REPORT

October Report

SUMMARY

  • Global share markets again moved lower during October as longer-term bond yields increased further and the economy continued to slow.
  • Quality growth stocks outperformed the broader market, as the technology sector made gains, while consumer spending showed signs of moderating further.
  • The Fund returned -0.2% in October, while the benchmark returned -1.1%.

We are pleased to include a recording of the investor update for the year to 30 June that was presented to shareholders at our recent AGM.

PORTFOLIO

Top Holdings (alphabetically)

Alphabet Inc
United States
Communication Services
Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.
Amazon.com Inc
United States
Consumer Discretionary
Amazon.com, Inc. is an online retailer that offers a wide range of products. The Company products include books, music, computers, electronics and numerous other products. Amazon offers personalized shopping services, Web-based credit card payment, and direct shipping to customers. Amazon also operates a cloud platform offering services globally.
CME Group Inc
United States
Financials
CME Group Inc. operates a derivatives exchange that trades futures contracts and options on futures, interest rates, stock indexes, foreign exchange, and commodities. The Company brings together buyers and sellers of derivatives products on its trading floors, electronic trading platform, and through privately negotiated transactions that it clears.
Deere & Co
United States
Industrials
Deere & Company manufactures and distributes a range of agricultural, construction, forestry, and commercial and consumer equipment. The Company supplies replacement parts for its own products and for those of other manufacturers. Deere also provides product and parts financing services. Deere and Company extends its services and products worldwide.
Meta Platforms Inc
United States
Communication Services
Meta Platforms, Inc. operates as a social technology company. The Company builds applications and technologies that help people connect, find communities, and grow businesses. Meta Platform is also involved in advertisements, augmented, and virtual reality.
Microsoft Corp
United States
Information Technology
Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Schneider Electric SE
France
Industrials
Schneider Electric SE manufactures electrical power products. The Company offers car chargers, home security goods, light switches, access control, sensors, valves, circuit breakers, cables, accessories, signaling devices, fuse, motor starters, and voltage transformers. Schneider Electric serves customers worldwide.
Thermo Fisher Scientific Inc
United States
Health Care
Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
UnitedHealth Group Inc
United States
Health Care
UnitedHealth Group Incorporated owns and manages organized health systems. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth serves customers in the United States.
Vertex Pharmaceuticals Inc
United States
Health Care
Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes pharmaceutical products. The Company develops drugs for the treatment of cystic fibrosis, cancer, inflammatory bowel, autoimmune disease, and neurological disorders. Vertex Pharmaceuticals serves healthcare sector worldwide.

Sector Breakdown

Capitalisation Breakdown

Region Breakdown

PERFORMANCE

PERFORMANCE SINCE STRATEGY INCEPTION

NET PERFORMANCE FOR PERIODS ENDING 31 Oct 20236

Pengana Harding Loevner International Fund Class B

The Class was established in 1 July 2015. From June 2021 Harding Loevner was appointed as the investment manager for the Fund.

1M 1Y 2Y
Since
Harding Loevner
Appointed June 20211
3Y 5Y
Since Fund
Inception
July 20152
Since Strategy
Inception
November 19893
Fund (APIR PCL0026AU)1,2

Managed by Harding Loevner from June 2021
-0.2% 11.1% -6.9% -1.5% 2.4% 7.6% 7.9%
Current Strategy (Partial Simulation)4

Harding Loevner Global Equity Strategy
3.0% 8.2% 9.5% 9.0%
Index5 -1.1% 11.6% 2.4% 5.5% 10.4% 9.9% 9.5% 7.0%

Swipe horizontally to see all columns

PERFORMANCE SINCE STRATEGY INCEPTION

NET PERFORMANCE SINCE INCEPTION7

COMMENTARY

Market Review 

The global equity market fell for a third consecutive month as inflation remained ‘sticky’ across major developed economies. Rising prospects of ‘higher-for-longer’ interest rates brought an increase in longer-term bond yields, which impacted most share prices. The outbreak of hostilities in the Middle East raised the level of geo-political risk and also oil prices. This dampened risk appetite, which led to gold having its best month since March.

The fall in share markets affected most sectors of the economy, although defensive sectors such as utilities and consumer discretionary provided some protection. Information technology outperformed upon stronger earnings reports by some companies in the sector. However, the more cyclical industrial companies were dragged down by the underperformance of large multinational capital goods companies.

China underperformed within the Emerging Markets universe, as factory orders shrank upon weaker global goods demand and slower construction activity.

Growth stocks outperformed value during October. Investors became more concerned about the impact of weaker consumer spending on corporate earnings growth and energy stocks weakened upon lower oil prices.

The Fund’s focus on high-quality stocks contributed to relative returns during October. The most-expensively-valued stocks relative to earnings outperformed, as the market’s highest-priced quintile declined by 3% less than the cheapest quintile.

Both these dynamics helped the Fund outperform the benchmark during the month.

Portfolio Comment

Strong stock performance in consumer discretionary, financials, and information technology contributed to relative returns. Weak stock performance and overweight positions in industrials and health care were the main detractors.

The underperformance of capital goods companies in October was perhaps a sign that global business sentiment is beginning to deteriorate. While it is impossible to accurately predict the future state of the economy, the Fund’s capital goods holdings are well placed to weather a range of challenging business environments that could materialise.

The Fund is significantly overweight in the capital goods industry, with investments in diverse high-quality businesses that possess strong competitive advantages. Moreover, they stand to benefit from the energy transition and changes in industrial policies (e.g. onshoring) and technologies (e.g. automation).

The Fund’s holdings include France-based digital automation and energy management group Schneider Electric the global leader in industrial electrification, John Deere the US-based expert in precision agriculture, and US-based Ametek, which produces ultra-precision instruments that monitor emission and power outputs.

Strong stock performance in the financials sector contributed to relative returns during October. Holdings in US financial exchanges CME Group and Tradeweb outperformed as rising market volatility led to higher trading volumes in bond and commodity markets.

The Fund’s lack of exposure to US-based global automotive and clean energy company Tesla also contributed to relative returns. During the month, CEO Elon Musk cautioned investors that interest rates were putting pressure on the company to raise prices, which could hamper demand.

Weak stock performance in the healthcare sector detracted from relative returns. Danish biotechnology company Genmab which specialises in developing cancer treatments underperformed on fears of greater-than-anticipated operating expenses. Meanwhile, life sciences tools company Thermo Fisher Scientific reported a decline in year-on-year organic growth, citing continued weakness in China and falling demand for COVID-19 testing.

PROFILE

STATISTICAL DATA2

PORTFOLIO SUMMARY
VOLATILITY8
11%
NUMBER OF STOCKS
61
BETA9
0.89

FEATURES

  • APIR CODE PCL0026AU
  • REDEMPTION PRICEA$ 0.8596
  • FEES * Management Fee: 0.974%
    Performance Fee: Nil
  • Minimum initial investment $10,000
  • FUM AT MONTH END A$ 40.93m
  • STRATEGY INCEPTION DATE 1 December 1989
  • BenchmarkMSCI All Country World Total Return Index (net) in $A

Fund Managers

Peter Baughan

Portfolio Manager

Jingyi Li

Portfolio Manager

Rick Schmidt

Portfolio Manager

Description

An International Fund targeting superior risk-adjusted returns through investing in high-quality and durable growing companies at reasonable prices.

The Pengana Harding Loevner International Fund invests in high-quality, growing companies identified through fundamental research with a long-term, global perspective.

Pengana has appointed Harding Loevner to managed the Fund.  Harding Loevner is a New Jersey-based global equity fund manager formed in 1989 with over US$86billion in Assets under Management.

Harding Loevner’ analysts search the world for companies that meet their high quality and durable growth criteria, conduct fundamental research, then value and rate their stocks to make them available to PMs for investment.

EXPLORE OUR FUNDS

Harding Loevner International Fund
Harding Loevner International Fund
Axiom International Fund
Axiom International Fund
Axiom International Fund (Hedged)
Axiom International Fund (Hedged)
Australian Equities Fund
Australian Equities Fund
High Conviction Property Securities Fund
High Conviction Property Securities Fund
Global Small Companies Fund
Global Small Companies Fund
WHEB Sustainable Impact Fund
WHEB Sustainable Impact Fund
Emerging Companies Fund
Emerging Companies Fund
High Conviction Equities Fund
High Conviction Equities Fund
Pengana International Equities Limited (ASX: PIA)
Pengana International Equities Limited (ASX: PIA)
Private Equity Trust (ASX: PE1)
Private Equity Trust (ASX: PE1)
Alpha Israel Fund
Alpha Israel Fund
Pengana Diversified Private Credit Fund
Pengana Diversified Private Credit Fund

1. Harding Loevner was appointed fund manager as of 10 May 2021. June 2021 represents the first full month of Harding Loevner managing the Fund.
2. Class B Inception date 1 July 2015. Figures shown are calculated from the continuous performance of both the current and previous strategies. For performance see row labelled Fund (APIR PCL0026AU) in the table above which is the continuous performance of both the current and previous (shaded) strategies.
3. Harding Loevner Global Equity Strategy inception 1 Dec 1989
4. Prior to June 2021, the Harding Loevner Global Equity Strategy performance (labelled ‘Current Strategy (Partial Simulation)’ and shown in the shaded area) includes the strategy performance simulated by Pengana from the monthly gross returns of the Harding Loevner Global Equity strategy. This simulation was done by: 1) the conversion of US-denominated gross returns to AUD, 2) applying the fee structure of Class B. From June 2021 the strategy performance is the performance of the Pengana Harding Loevner International Fund Class B.
5. MSCI All Country World Total Return Index in AUD.
6. Performance for periods greater than 12 months are annualised. Net performance figures are shown after all fees and expenses and assume reinvestment of distributions. No allowance has been made for buy/sell spreads. Please refer to the PDS for information regarding risks. Past performance is not a reliable indicator of future performance, the value of investments can go up and down.
7. The Harding Loevner Global Equity Strategy performance (shown in the shaded area in the chart, and in the performance table as row labeled ‘Harding Loevner Global Equity Strategy) has been simulated by Pengana from the monthly gross returns of the Harding Loevner Global Equity strategy. This simulation was done by: 1) the conversion of US-denominated gross returns to AUD, 2) applying the fee structure of the stated class. Strategy Inception 30 November 1989.
8. Annualised standard deviation since inception.
9. Relative to MSCI All Country World Total Return Index in AUD
* For further information regarding fees please see the PDS available on our website.